Scott Schwartz, M.D., interventional radiologist and program director for IR residencies and the vascular and interventional radiology fellowship at Henry Ford Hospital, explains how the department uses Yttrium-90 (Y90) embolization therapy to treat liver cancer.
Find more content on Henry Ford Hospital
Related Articles on Y-90 Radiotherapy:
Current Advances in Targeted Radionuclide Therapy
A Look Ahead in Targeted Radionuclide Therapy
Radioactive Bead Therapy Now Used for Head, Neck Tumors
NCCN Guidelines Recommend Y-90 Microspheres for Metastatic Colorectal Cancer Treatment